InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

77
Insider
Date
Role
Action
Shares
Price
Amount
Sean Maduck
3 Nov 2026
See Remarks
Sold after exercise
4,542
$82.68
$375.51K
Sean Maduck
3 Nov 2026
See Remarks
Sold after exercise
8,617
$82.02
$706.76K
Roberto Wandenkolk Vieira
2 Nov 2026
President, Oncology
Sold after exercise
1,676
$81.52
$136.63K
Roberto Wandenkolk Vieira
2 Nov 2026
President, Oncology
Sold after exercise
6,657
$80.73
$537.44K
Sean Maduck
2 Nov 2026
See Remarks
Sold after exercise
11,841
$81.42
$964.07K
Sean Maduck
2 Oct 2026
See Remarks
Sold after exercise
8,744
$116.55
$1.02M
Sean Maduck
2 Oct 2026
See Remarks
Sold after exercise
15,843
$116.12
$1.84M
Joseph Douglas Lyon
2 Oct 2026
See Remarks
Sold after exercise
4,744
$116.54
$552.87K
Joseph Douglas Lyon
2 Oct 2026
See Remarks
Sold after exercise
4,446
$115.70
$514.39K
Roberto Wandenkolk Vieira
2 Oct 2026
President, Oncology
Sold after exercise
5,147
$116.59
$600.06K
Roberto Wandenkolk Vieira
2 Oct 2026
President, Oncology
Sold after exercise
2,086
$115.73
$241.41K
Roberto Wandenkolk Vieira
2 Oct 2026
President, Oncology
Sold after exercise
1,100
$114.52
$125.97K
Sean Maduck
1 Oct 2026
See Remarks
Sold after exercise
413
$115.54
$47.72K
Joseph Douglas Lyon
1 Oct 2026
See Remarks
Sold after exercise
810
$115.40
$93.47K
Joseph Douglas Lyon
14 Sep 2026
See Remarks
Sold after exercise
2,188
$114.12
$249.69K
Joseph Douglas Lyon
14 Sep 2026
See Remarks
Sold after exercise
7,812
$113.32
$885.26K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
1,225
$115.44
$141.41K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
5,621
$114.58
$644.04K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
1,606
$113.72
$182.63K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
974
$112.40
$109.47K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
1,537
$111.37
$171.18K
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
23,770
$110.70
$2.63M
Roberto Wandenkolk Vieira
2 Sep 2026
President, Oncology
Sold after exercise
23,600
$109.35
$2.58M
Sean Maduck
1 Sep 2026
See Remarks
Sold after exercise
2,281
$115.61
$263.71K
Sean Maduck
1 Sep 2026
See Remarks
Sold after exercise
10,989
$114.71
$1.26M
Sean Maduck
1 Sep 2026
See Remarks
Sold after exercise
11,730
$113.94
$1.34M
Kimberly Park
26 Aug 2026
Director
Sold after exercise
26,685
$122.55
$3.27M
Sean Maduck
25 Aug 2026
See Remarks
Sold after exercise
5,870
$126.06
$739.97K
Sean Maduck
25 Aug 2026
See Remarks
Sold after exercise
25,085
$125.47
$3.15M
Sean Maduck
14 Aug 2026
See Remarks
Sold after exercise
3,664
$114.49
$419.49K
William Guyer
10 Aug 2026
Chief Development Officer
Sold after exercise
4,770
$114.04
$543.96K
William Guyer
10 Aug 2026
Chief Development Officer
Sold after exercise
11,530
$113.18
$1.30M
Sean Maduck
10 Aug 2026
See Remarks
Sold after exercise
1,031
$114.52
$118.07K
William Guyer
4 Aug 2026
Chief Development Officer
Sold after exercise
3,700
$113.12
$418.56K
Sean Maduck
3 Aug 2026
See Remarks
Sold after exercise
20,305
$114.70
$2.33M
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
1,001
$120.67
$120.80K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,103
$119.95
$971.94K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,783
$118.73
$567.91K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,267
$117.93
$974.95K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
7,089
$116.96
$829.10K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
14,222
$115.87
$1.65M
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
15,477
$114.96
$1.78M
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,700
$113.18
$531.94K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
600
$110.95
$66.57K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
2,202
$110.03
$242.28K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
400
$108.46
$43.38K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,956
$106.96
$957.89K
Atabak Mokari
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,200
$105.54
$443.25K
Atabak Mokari
15 Jul 2026
Chief Financial Officer
Sold after exercise
101
$89.43
$9.03K
Atabak Mokari
15 Jul 2026
Chief Financial Officer
Sold after exercise
3,520
$88.30
$310.82K
Atabak Mokari
15 Jul 2026
Chief Financial Officer
Sold after exercise
28,460
$87.89
$2.50M
Atabak Mokari
15 Jul 2026
Chief Financial Officer
Sold after exercise
7,919
$86.78
$687.18K
William Guyer
7 Jul 2026
Chief Development Officer
Sold after exercise
952
$93.54
$89.05K
William Guyer
7 Jul 2026
Chief Development Officer
Sold after exercise
19,048
$93.11
$1.77M
Sean Maduck
1 Jul 2026
See Remarks
Sold after exercise
11,175
$89.31
$998.03K
Sean Maduck
1 Jul 2026
See Remarks
Sold after exercise
2,801
$88.51
$247.92K
Sean Maduck
1 Jul 2026
See Remarks
Sold after exercise
11,024
$87.33
$962.78K
Atabak Mokari
15 Jun 2026
Chief Financial Officer
Sold after exercise
2
$82.45
$164.90
Atabak Mokari
15 Jun 2026
Chief Financial Officer
Sold after exercise
19,483
$81.81
$1.59M
Atabak Mokari
15 Jun 2026
Chief Financial Officer
Sold after exercise
11,081
$80.94
$896.92K
Atabak Mokari
15 Jun 2026
Chief Financial Officer
Sold after exercise
9,434
$80.02
$754.92K
William Guyer
2 Jun 2026
Chief Development Officer
Sold after exercise
20,000
$70.60
$1.41M
Atabak Mokari
1 Jun 2026
Chief Financial Officer
Sold after exercise
40,000
$70.00
$2.80M
Sean Maduck
1 Jun 2026
See Remarks
Sold after exercise
3,931
$70.75
$278.10K
Sean Maduck
1 Jun 2026
See Remarks
Sold after exercise
21,069
$70.11
$1.48M
Sean Maduck
27 May 2026
See Remarks
Sold after exercise
20,425
$66.16
$1.35M
Sean Maduck
27 May 2026
See Remarks
Sold after exercise
54,575
$65.37
$3.57M
William Guyer
5 May 2026
Chief Development Officer
Sold after exercise
20,000
$51.83
$1.04M
William Guyer
7 Apr 2026
Chief Development Officer
Sold after exercise
20,000
$40.97
$819.40K
William Guyer
20 Mar 2026
Chief Development Officer
Sold after exercise
11,767
$36.01
$423.73K
William Guyer
4 Mar 2026
Chief Development Officer
Sold after exercise
8,233
$35.99
$296.35K
William Guyer
3 Feb 2026
Chief Development Officer
Sold after exercise
20,000
$40.87
$817.33K
William Guyer
6 Jan 2026
Chief Development Officer
Sold after exercise
20,000
$35.18
$703.66K
William Guyer
2 Dec 2025
Chief Development Officer
Sold after exercise
640
$80.88
$51.76K
William Guyer
2 Dec 2025
Chief Development Officer
Sold after exercise
19,360
$80.05
$1.55M
Joseph Douglas Lyon
1 Dec 2025
See Remarks
Sold after exercise
5,000
$79.53
$397.63K
Sean Maduck
1 Dec 2025
See Remarks
Sold after exercise
20,000
$79.52
$1.59M
Show all 119 transactions →

What was left out

Form 4 filings counted 99
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 77
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,647,551
History held since 3 Oct 2006